SZSE: 301301 - Yili Chuannig Biotechnology Co., Ltd.

Yield per half year: +12.21%
Sector: Healthcare

Reporting Yili Chuannig Biotechnology Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
19.49
Выручка, млрд ¥
4.09
Чистая прибыль, млрд ¥
0.4864
EV, млрд ¥
21.44
EBITDA, млрд ¥
1.32


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
1.03
Долг, млрд ¥
2.97


Share

IFRS
Reporting Annual Quarterly
2022 2023 2024 LTM 5 year average CAGR 5
EPS 0.0356 0.4231 0.24
Цена акции ао 9.61 9.09 10.66 10.66


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 8.71 17.91
ROA, % 4.94 8.30
ROS, % 11.89 11.89 11.89 11.89 23.77
Рентаб EBITDA, % 18.81 26.51
Чистая рентаб, % 11.88 23.79
Operation Margin, % 0 0 0 0 0.00


Coefficients

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
36.54 33.38
P/BV
3.06 5.66
P/S
4.3 9.95
P/FCF
0 0 0 0 0.00
E/P
0.025 0.025 0.025 0.025 0.04
EV/EBITDA
30.12 25.59
EV/Ebit
0 0 0
EV/S
5.24 5.24 5.24 5.24 9.50
EV/FCF
0 0 0 0.00
Debt/EBITDA
2.25 2.25 2.25 2.25 0.59
Netdebt/Ebitda
0 0 0 0 0.00
Debt/Ratio
0 0 0 0 0.00
Debt/Equity
0 0 0 0 0.00
Debt/Net Income
6.11 6.11 6.11 6.11 0.75
Бета
0 -0.7358 4.1 4.1 2.68
Индекс Альтмана
0 0 0 0 0.00


Dividends

IFRS
Reporting Annual Quarterly
2023 LTM Industry average 5 year average CAGR 5
Дивиденд
0.093 0.09
Див доход, ао, %
1.02 1.04 1.17
Дивиденды / прибыль, %
0 29.29


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
2779 2779